RE: RE: LeoThread 2026-02-01 01-12
You are viewing a single comment's thread from:

RE: LeoThread 2026-02-01 01-12

Words
37
Reading
1 min
Listen
Play
8M
  1. Neuralink has expanded human trials to 21 participants worldwide, up from 12 reported late last year. The effort has shifted from basic cursor control toward a "Telepathy" approach for people with ALS and spinal cord injuries
@chammy: Neuralink has | Ecency